(Q34566473)

3 August 2017

1 reference

title

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis (English)

1 reference

3 August 2017

0 references

1 reference

R T Schapiro

1

1 reference

3 August 2017

publication date

1 May 2001

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

299-302

1 reference

A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Acute radicular pain as a presenting symptom in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0034-6

Amantadine is beneficial in restless legs syndrome

21 January 2018

1 reference

12 December 2020

Neuropathophysiology of movement disorders in cerebral palsy

1 reference

12 December 2020

Paroxysmal convergence spasm in multiple sclerosis

1 reference

12 December 2020

Paroxysmal superior rectus and levator palpebrae spasm: a unique presentation of multiple sclerosis

1 reference

12 December 2020

Cannabis and cannabinoids: pharmacology and rationale for clinical use.

1 reference

12 December 2020

Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin

1 reference

12 December 2020

Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions

1 reference

12 December 2020

Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis

1 reference

12 December 2020

Movement disorders in multiple sclerosis

1 reference

12 December 2020

Pharmacology of cannabinoid receptor ligands.

1 reference

12 December 2020

Gamma knife radiosurgery for trigeminal neuralgia: results and expectations

1 reference

12 December 2020

Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue

1 reference

12 December 2020

Traditional pharmacological treatments for spasticity. Part II: General and regional treatments

1 reference

12 December 2020

Spasticity: a review.

1 reference

12 December 2020

Acute and chronic pain syndromes in multiple sclerosis

1 reference

12 December 2020

Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

1 reference

12 December 2020

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

1 reference

12 December 2020

Gabapentin for the treatment of spasticity in patients with spinal cord injury

1 reference

12 December 2020

PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS

1 reference

12 December 2020

Clonazepam, Baclofen and Placebo in the Treatment of Spasticity

1 reference

12 December 2020

Chronic and acute pain syndromes in patients with multiple sclerosis

1 reference

12 December 2020

Treatment of spastic paresis

1 reference

12 December 2020

Pain in multiple sclerosis

1 reference

12 December 2020

Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.

1 reference

12 December 2020

Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine.

1 reference

12 December 2020

Intrathecal baclofen for severe spinal spasticity

1 reference

12 December 2020

Open label gabapentin treatment for pain in multiple sclerosis

1 reference

12 December 2020

Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients

1 reference

12 December 2020

Pathophysiology of spasticity.

1 reference

12 December 2020

Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin

1 reference

12 December 2020

Treatment of spasticity with botulinum toxin: a double-blind study

1 reference

12 December 2020

Gabapentin for relief of spasticity associated with multiple sclerosis

1 reference

12 December 2020

Pendulum testing of spasticity

1 reference

12 December 2020

Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features

1 reference

12 December 2020

Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol)

1 reference

12 December 2020

Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial

1 reference

12 December 2020

Epilepsy in multiple sclerosis

1 reference

12 December 2020

10.1007/S11910-001-0034-6

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1045783158

0 references

1 reference